| 摘要 |
ABSTRACT - 603155 The disclosure relates to compositions comprising a compound having a structure according to Formula A or Formula B: or a pharmaceutically acceptable salt, tautomer or hydrate thereof, where X2 is a bond or linker, X3 is bond or -PO4-, and X1, R1, R2, R3, and n are as described in the specification. These compounds are suitable for treating cancer conditions selected from a bladder cancer condition, skin precancerous or cancerous condition. Also disclosed are methods for making and using such compounds and compositions. |
